Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $2.6 million.

  • Ekso Bionics Holdings' Shares Outstanding (Weighted Average) rose 9320.53% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 9320.53%. This contributed to the annual value of $13.0 million for FY2022, which is 630.69% up from last year.
  • Per Ekso Bionics Holdings' latest filing, its Shares Outstanding (Weighted Average) stood at $2.6 million for Q3 2025, which was up 9320.53% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Shares Outstanding (Weighted Average) ranged from a high of $25.4 million in Q1 2025 and a low of $1.2 million during Q2 2024
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $12.7 million (2022), whereas its average is $11.2 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 10212.43% in 2021, then crashed by 9109.04% in 2024.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Shares Outstanding (Weighted Average) stood at $12.2 million in 2021, then grew by 6.31% to $13.0 million in 2022, then increased by 8.57% to $14.1 million in 2023, then tumbled by 90.38% to $1.4 million in 2024, then soared by 93.21% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $2.2 million for Q2 2025, and $25.4 million during Q1 2025.